Pitched as closing a deadly gap so no one skips a life-saving smear because of the cost, Labour says it would make cervical screening free for every eligible New Zealander aged 25 to 69.

The Policy: Labour Free Cervical Screening — 2026 Election →

What it does:

• Removes the patient fee for cervical screening for everyone in the 25–69 programme, delivered through Labour's proposed "Medicard"; the party says it would cover about 1.4 million people and cost roughly $20 million a year, while news coverage has put the first-year cost at $21.6 million, funded from within existing health baselines rather than new tax.
• Targets a real cost barrier: screening is already free for Māori and Pacific people aged 25–69, Community Services Card holders, and some never- or under-screened over-30s, but everyone else "must pay a General Practice fee", and about half of women who get screened currently pay.
• Would take effect from October 2027, presented at a GP or community event, with screening on a five-yearly HPV-test cycle.
• Sits inside New Zealand's goal to eliminate cervical cancer by 2030; about 175 New Zealanders are diagnosed and 55 die each year, and screening coverage remains uneven — the Ministry of Health's 2024 figures show Māori at 64.6% and Pacific at 71.2% versus 78.5% for European/Other.

The result: As an Opposition pledge ahead of the 2026 election it is not law and depends on Labour winning office, so it remains a promise rather than a delivered change. Labour health spokesperson Dr Ayesha Verrall argues screening is highly cost-effective — "for every dollar you spend, you save three" in some research — and points to participation rising when fees were dropped for priority groups. The funding claim is contestable: the policy leans on absorbing the cost inside baselines at a time when Health Minister Dr Shane Reti's government has committed only to keeping screening free for higher-risk groups. The wider Medicard package it belongs to is opposed by National's Health Minister Simeon Brown, who calls universal free health entitlements "untargeted" and warns they could "clog up" GP access; Verrall counters the status quo does nothing for those who cannot afford a visit.

The impacts to watch:

• Whether removing the fee lifts coverage further: HPV self-testing has already driven gains, with 81% now choosing to self-test and coverage up 7.4% in the two years to July 2025, per Victoria University's Professor Bev Lawton.
• Equity: fees fall hardest on lower-income and under-screened groups, so a universal free offer could narrow the Māori, Pacific and Asian coverage gaps — or have limited extra effect if those groups are already eligible for free tests.
• Cost discipline: funding it "from baselines" raises questions about trade-offs against other health spending if uptake rises faster than the $20–21.6 million budgeted.
• General-practice capacity: more screens, plus the broader Medicard, would add demand on already-stretched GPs and community providers.